298 related articles for article (PubMed ID: 21685909)
1. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
Patel N; Durkin L; Bodo J; Hsi ED
Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas.
Menter T; Trivedi P; Ahmad R; Flora R; Dirnhofer S; Tzankov A; Naresh KN
Am J Clin Pathol; 2017 Mar; 147(3):292-300. PubMed ID: 28395058
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of lymphoid enhancer-binding factor 1 in Hodgkin lymphoma.
Ravindran A; Kurtin PJ; King RL; Yuan J; Feldman AL; Rech KL; McPhail ED; Parikh SA; Ding W; Shi M
Hum Pathol; 2022 Jul; 125():2-10. PubMed ID: 35421421
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry for LEF1 and SOX11 adds diagnostic specificity in small B-cell lymphomas.
Rangan A; Reinig E; McPhail ED; Rech KL
Hum Pathol; 2022 Mar; 121():29-35. PubMed ID: 35066013
[TBL] [Abstract][Full Text] [Related]
8. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
Yoshino T; Tanaka T; Sato Y
J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
[TBL] [Abstract][Full Text] [Related]
10. Expression of LEF1 in mantle cell lymphoma.
O'Malley DP; Lee JP; Bellizzi AM
Ann Diagn Pathol; 2017 Feb; 26():57-59. PubMed ID: 28038713
[TBL] [Abstract][Full Text] [Related]
11. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
12. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
[TBL] [Abstract][Full Text] [Related]
13. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
15. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas.
Moore EM; Swerdlow SH; Gibson SE
Am J Surg Pathol; 2018 Mar; 42(3):342-350. PubMed ID: 29309299
[TBL] [Abstract][Full Text] [Related]
17. [A study of LEF1 protein expression in diagnosis and differential diagnosis of lymphoblastic lymphoma/acute lymphoblastic leukemia].
Chen X; Rui WW; Bi K; Wu YJ; Zhang SX; Zhang L; Yu J; Xiu B; Yi XH; Zeng Y
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):207-212. PubMed ID: 33677883
[No Abstract] [Full Text] [Related]
18. Downregulation of Lymphoid enhancer-binding factor 1 (LEF-1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features.
Soliman DS; Al-Kuwari E; Siveen KS; Al-Abdulla R; Chandra P; Yassin M; Nashwan A; Hilmi FA; Taha RY; Nawaz Z; El-Omri H; Mateo JM; Al-Sabbagh A
Int J Lab Hematol; 2021 Jun; 43(3):515-525. PubMed ID: 33314668
[TBL] [Abstract][Full Text] [Related]
19. Relevance of Additional Immunohistochemical Markers in the Differential Diagnosis of Small B-Cell Lymphomas: A Case-Control Study.
Kıvrak H; Yüksel S; Ateş C; Merter M; Kaygusuz G; Özcan M; Kuzu I
Turk J Haematol; 2022 Aug; 39(3):178-187. PubMed ID: 34619856
[TBL] [Abstract][Full Text] [Related]
20. LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
Menter T; Dirnhofer S; Tzankov A
J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]